Momentum investing is essentially the opposite of the tried-and-tested Wall Street adage -- "buy low and sell high." Investors following this investing style typically avoid betting on cheap stocks and waiting long for them to recover. They believe instead that one could make far more money in lesser time by "buying high and selling higher."Everyone likes betting on fast-moving trending stocks, but it isn't easy to determine the right entry point. These stocks often lose momentum when their future growth po ...

Core Viewpoint - Momentum investing focuses on "buying high and selling higher," contrasting with traditional strategies of "buying low and selling high" [1] Group 1: Momentum Investing Strategy - Momentum investing can be risky as stocks may lose momentum if future growth does not justify high valuations [1] - A safer approach involves investing in bargain stocks that exhibit recent price momentum [2] Group 2: Cushman & Wakefield (CWK) Analysis - CWK has shown a price increase of 8.1% over the past four weeks, indicating growing investor interest [3] - The stock gained 35.6% over the past 12 weeks, demonstrating its ability to deliver positive returns over a longer timeframe [4] - CWK has a beta of 1.43, suggesting it moves 43% higher than the market in either direction [4] - CWK has a Momentum Score of B, indicating a favorable time to invest [5] - The stock has a Zacks Rank 2 (Buy) due to upward trends in earnings estimate revisions, which attract more investors [6] - CWK is trading at a Price-to-Sales ratio of 0.27, meaning investors pay 27 cents for each dollar of sales, indicating a reasonable valuation [6] Group 3: Investment Opportunities - CWK appears to have significant potential for growth at a fast pace [7] - There are other stocks that also meet the criteria of the 'Fast-Paced Momentum at a Bargain' screen, suggesting additional investment opportunities [7] - Zacks offers over 45 Premium Screens to help identify winning stock picks based on various investing styles [8]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Evercore (EVR) - Evercore currently holds a Momentum Style Score of B and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [2][3] - The stock has shown significant price performance, with a 1.4% increase over the past week, compared to a 0.82% decline in the Zacks Financial - Investment Bank industry [5] - Over the past quarter, Evercore shares have risen 66.78%, and 23.79% over the last year, outperforming the S&P 500's gains of 16.27% and 12.91%, respectively [6] Trading Volume - Evercore's average 20-day trading volume is 583,648 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, two earnings estimates for Evercore have increased, raising the consensus estimate from $10.79 to $11.71 [9] - For the next fiscal year, two estimates have also moved upwards, with no downward revisions noted [9] Conclusion - Given the strong performance metrics and positive earnings outlook, Evercore is positioned as a 1 (Strong Buy) stock with a Momentum Score of B, making it a compelling investment option [11]

Company Overview - Ducommun (DCO) currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 1 (Strong Buy), suggesting a favorable outlook compared to the market [3] Price Performance - DCO shares have increased by 0.94% over the past week, outperforming the Zacks Aerospace - Defense Equipment industry, which rose by 0.15% [5] - Over the last month, DCO's price change is 13.92%, significantly higher than the industry's 7.41% [5] - In the last quarter, DCO shares have surged by 60.02%, and over the past year, they have gained 46.68%, while the S&P 500 has only moved 16.27% and 12.91% respectively [6] Trading Volume - DCO's average 20-day trading volume is 153,468 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, one earnings estimate for DCO has increased, raising the consensus estimate from $3.65 to $3.68 [9] - For the next fiscal year, one estimate has also moved upwards with no downward revisions during the same period [9] Conclusion - Given the strong price performance, positive earnings outlook, and high momentum score, DCO is positioned as a promising investment opportunity [11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell even higher, with the expectation that established trends will continue [1] Company Overview: Robinhood Markets, Inc. (HOOD) - Robinhood currently holds a Momentum Style Score of B and a Zacks Rank of 1 (Strong Buy), indicating strong potential for outperformance [3][4] - The stock has shown significant price increases, with a 150.84% rise over the past quarter and a 317.54% increase over the last year, compared to the S&P 500's gains of 16.27% and 12.91% respectively [7] Price Performance - Over the past week, HOOD shares increased by 4.17%, while the Zacks Financial - Investment Bank industry declined by 0.82% [6] - The monthly price change for HOOD is 30.24%, outperforming the industry's 8.93% [6] Trading Volume - HOOD's average 20-day trading volume is 49,042,924 shares, which is a useful indicator of market interest and price movement [8] Earnings Outlook - In the past two months, three earnings estimates for HOOD have been revised upwards, increasing the consensus estimate from $1.22 to $1.26 [10] - For the next fiscal year, three estimates have also moved higher, with no downward revisions [10] Conclusion - Given the strong momentum indicators and positive earnings outlook, HOOD is positioned as a promising investment opportunity [12]

Group 1 - The core concept of momentum investing involves following a stock's recent price trends, with the aim of buying high and selling even higher [1] - ARS Pharmaceuticals, Inc. (SPRY) currently holds a Momentum Style Score of B and a Zacks Rank of 2 (Buy), indicating potential for outperformance [2][3] - SPRY shares have increased by 7.08% over the past week, significantly outperforming the Zacks Medical - Drugs industry, which rose by 1.75% during the same period [5] Group 2 - Over the past quarter, SPRY shares have risen by 25%, and over the last year, they have increased by 53.52%, while the S&P 500 has only moved 16.27% and 12.91%, respectively [6] - The average 20-day trading volume for SPRY is 1,516,745 shares, which is a bullish indicator when combined with rising stock prices [7] - In the last two months, one earnings estimate for SPRY has moved higher, increasing the consensus estimate from -$1.49 to -$1.44, with two upward revisions for the next fiscal year [9] Group 3 - Given the positive momentum indicators and earnings outlook, SPRY is positioned as a promising stock for near-term gains, making it a candidate for investors' short lists [11]

Company Overview - SoFi Technologies, Inc. (SOFI) currently holds a Momentum Style Score of B, indicating a positive momentum outlook [2] - The company has a Zacks Rank of 2 (Buy), suggesting strong potential for outperformance in the market [3] Price Performance - Over the past week, SOFI shares have increased by 14.16%, while the Zacks Financial - Miscellaneous Services industry remained flat [5] - In a longer time frame, SOFI's monthly price change is 43.15%, significantly outperforming the industry's 7.71% [5] - Over the last three months, SOFI shares have risen by 99.53%, and they are up 191% over the past year, compared to the S&P 500's increases of 16.27% and 12.91%, respectively [6] Trading Volume - SOFI's average 20-day trading volume is 73,020,280 shares, which is a useful indicator of market interest and price movement [7] Earnings Outlook - In the past two months, three earnings estimates for SOFI have been revised upwards, while none have been lowered, leading to an increase in the consensus estimate from $0.27 to $0.28 [9] - For the next fiscal year, two estimates have moved upwards, while one has been revised downwards [9] Conclusion - Considering the positive price trends, trading volume, and earnings outlook, SOFI is positioned as a 2 (Buy) stock with a Momentum Score of B, making it a potential candidate for near-term investment [11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell even higher, with the expectation that established trends will continue [1] Company Overview: WNS (Holdings) Limited - WNS currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting it is positioned for potential outperformance in the market [3] Performance Metrics - WNS shares have increased by 14.26% over the past week, while the Zacks Business - Services industry remained flat [5] - Over the past month, WNS's price change is 25.7%, significantly outperforming the industry's 1.35% [5] - In the last quarter, WNS shares rose by 17.18%, and over the past year, they gained 28.86%, compared to the S&P 500's increases of 16.27% and 12.91%, respectively [6] Trading Volume - The average 20-day trading volume for WNS is 3,272,020 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, one earnings estimate for WNS has increased, raising the consensus estimate from $4.59 to $4.60 [9] - For the next fiscal year, one estimate has also moved upwards, with no downward revisions during the same period [9] Conclusion - Given the strong performance metrics and positive earnings outlook, WNS is identified as a promising momentum pick with a Momentum Score of A and a Zacks Rank of 2 (Buy) [11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, with the aim of buying high and selling higher, capitalizing on established price movements [1] Company Overview: Verona Pharma PLC (VRNA) - VRNA currently holds a Momentum Style Score of B, indicating a positive momentum outlook [2] - The stock has a Zacks Rank of 1 (Strong Buy), suggesting strong potential for outperformance in the market [3] Performance Metrics - Over the past week, VRNA shares have increased by 14.53%, significantly outperforming the Zacks Medical - Biomedical and Genetics industry, which rose by 2.16% [5] - In a longer timeframe, VRNA shares have gained 74.25% over the past quarter and 386.84% over the last year, while the S&P 500 has only increased by 16.27% and 12.91%, respectively [6] Trading Volume - The average 20-day trading volume for VRNA is 6,108,280 shares, indicating strong interest and a bullish sentiment in the stock [7] Earnings Outlook - In the last two months, three earnings estimates for VRNA have been revised upwards, with the consensus estimate increasing from $0.16 to $0.22 [9] - For the next fiscal year, two estimates have also moved higher, with no downward revisions noted [9] Conclusion - Given the strong performance metrics and positive earnings outlook, VRNA is positioned as a promising investment opportunity with a Momentum Score of B and a Zacks Rank of 1 (Strong Buy) [11]

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Affiliated Managers Group (AMG) - AMG currently holds a Momentum Style Score of A, indicating strong momentum characteristics [2] - The company has a Zacks Rank of 2 (Buy), suggesting a favorable outlook compared to the market [3] Performance Metrics - AMG shares have increased by 1.74% over the past week, outperforming the Zacks Financial - Investment Management industry, which rose by 0.14% [5] - Over the past month, AMG's price change is 12.02%, significantly higher than the industry's 6.16% [5] - In the last quarter, AMG shares have risen by 34.65%, and over the past year, they have gained 22.72%, while the S&P 500 has increased by 16.27% and 12.91% respectively [6] Trading Volume - AMG's average 20-day trading volume is 228,560 shares, which serves as a bullish indicator when combined with rising stock prices [7] Earnings Outlook - In the past two months, five earnings estimates for AMG have been revised upwards, with no downward revisions, leading to an increase in the consensus estimate from $22.78 to $23.33 [9] - For the next fiscal year, five estimates have also moved higher without any downward revisions [9] Conclusion - Given the strong performance metrics and positive earnings outlook, AMG is positioned as a 2 (Buy) stock with a Momentum Score of A, making it a potential candidate for near-term investment [11]